NKT Cells in Tumor Immunity

作者: Masaki Terabe , Jay A. Berzofsky

DOI: 10.1016/B978-0-12-374279-7.17010-9

关键词:

摘要: NKT cells are a small subset of true T that bridge between the innate and adaptive immune systems, provide cellular system with means to recognize lipid antigens, interact regulate other parts system. In particular, they tumor immunity both positively negatively. They defined by their recognition antigens presented nonclassical MHC molecule CD1d, rather than conventional class I or II molecules. Classical type use semi-invariant cell receptor conserved alpha chain in mice humans, alpha-galactosylceramide its homologues, generally promote immunity. Type diverse receptors, lipids such as sulfatide, usually suppress These two subsets also cross-regulate each influence immunoregulatory cells. The balance along axis can have profound effects on immunosurveillance immunity, well vaccine responses. Harnessing these fight cancer is being undertaken clinical trials beginning show promise.

参考文章(117)
K Motoki, Y Koezuka, E Kobayashi, T Uchida, H Fukushima, KRN7000, a novel immunomodulator, and its antitumor activities. Oncology Research. ,vol. 7, pp. 529- 534 ,(1995)
J. B. Swann, J. M. C. Coquet, M. J. Smyth, D. I. Godfrey, CD1-Restricted T Cells and Tumor Immunity Current Topics in Microbiology and Immunology. ,vol. 314, pp. 293- 323 ,(2007) , 10.1007/978-3-540-69511-0_12
Laurent Brossay, Richard Locksley, Susanna Cardell, Shabnam Tangri, Mark Bix, Mitchell Kronenberg, Mouse CD1-Autoreactive T Cells Have Diverse Patterns of Reactivity to CD1+ Targets Journal of Immunology. ,vol. 160, pp. 3681- 3688 ,(1998)
Li Bai, Damien Picard, Brian Anderson, Vinod Chaudhary, Adrienne Luoma, Bana Jabri, Erin J. Adams, Paul B. Savage, Albert Bendelac, The majority of CD1d-sulfatide-specific T cells in human blood use a semiinvariant Vδ1 TCR. European Journal of Immunology. ,vol. 42, pp. 2505- 2510 ,(2012) , 10.1002/EJI.201242531
Maria Blomqvist, Sara Rhost, Susann Teneberg, Linda Löfbom, Thomas Østerbye, Manfred Brigl, Jan-Eric Månsson, Susanna L. Cardell, Multiple tissue-specific isoforms of sulfatide activate CD1d-restricted type II NKT cells. European Journal of Immunology. ,vol. 39, pp. 1726- 1735 ,(2009) , 10.1002/EJI.200839001
Dale I. Godfrey, H. Robson MacDonald, Mitchell Kronenberg, Mark J. Smyth, Luc Van Kaer, NKT cells: what's in a name? Nature Reviews Immunology. ,vol. 4, pp. 231- 237 ,(2004) , 10.1038/NRI1309
Masaki Terabe, So Matsui, Nancy Noben-Trauth, Hangjiong Chen, Cynthia Watson, Debra D. Donaldson, David P. Carbone, William E. Paul, Jay A. Berzofsky, NKT cell-mediated repression of tumor immunosurveillance by IL-13 and the IL-4R-STAT6 pathway. Nature Immunology. ,vol. 1, pp. 515- 520 ,(2000) , 10.1038/82771
Mark J. Smyth, Dale I. Godfrey, NKT cells and tumor immunity--a double-edged sword. Nature Immunology. ,vol. 1, pp. 459- 460 ,(2000) , 10.1038/82698
Niranjana A. Nagarajan, Mitchell Kronenberg, Invariant NKT Cells Amplify the Innate Immune Response to Lipopolysaccharide Journal of Immunology. ,vol. 178, pp. 2706- 2713 ,(2007) , 10.4049/JIMMUNOL.178.5.2706
Randy R. Brutkiewicz, CD1d Ligands: The Good, the Bad, and the Ugly Journal of Immunology. ,vol. 177, pp. 769- 775 ,(2006) , 10.4049/JIMMUNOL.177.2.769